These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 17081666

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Is special FDA regulation of nanomedicine needed? A conversation with Norris E. Alderson. Interview by Barbara J Culliton.
    Alderson NE.
    Health Aff (Millwood); 2008; 27(4):w315-7. PubMed ID: 18559355
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Emerging trends of nanomedicine--an overview.
    Sandhiya S, Dkhar SA, Surendiran A.
    Fundam Clin Pharmacol; 2009 Jun; 23(3):263-9. PubMed ID: 19527298
    [Abstract] [Full Text] [Related]

  • 6. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
    Fadeel B, Garcia-Bennett AE.
    Adv Drug Deliv Rev; 2010 Mar 08; 62(3):362-74. PubMed ID: 19900497
    [Abstract] [Full Text] [Related]

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 08; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 8. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
    Oberdörster G.
    J Intern Med; 2010 Jan 08; 267(1):89-105. PubMed ID: 20059646
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nanotoxicology and nanomedicine: making hard decisions.
    Linkov I, Satterstrom FK, Corey LM.
    Nanomedicine; 2008 Jun 08; 4(2):167-71. PubMed ID: 18329962
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Toward the emergence of nanoneurosurgery: part III--nanomedicine: targeted nanotherapy, nanosurgery, and progress toward the realization of nanoneurosurgery.
    Leary SP, Liu CY, Apuzzo ML.
    Neurosurgery; 2006 Jun 08; 58(6):1009-26; discussion 1009-26. PubMed ID: 16723880
    [Abstract] [Full Text] [Related]

  • 14. Nanomedicine in ophthalmology: the new frontier.
    Zarbin MA, Montemagno C, Leary JF, Ritch R.
    Am J Ophthalmol; 2010 Aug 08; 150(2):144-162.e2. PubMed ID: 20670739
    [Abstract] [Full Text] [Related]

  • 15. Exploring emerging nanobiotechnology drugs and medical devices.
    Paradise J, Diliberto GM, Tisdale AW, Kokkoli E.
    Food Drug Law J; 2008 Aug 08; 63(2):407-20. PubMed ID: 18561467
    [No Abstract] [Full Text] [Related]

  • 16. Emerging nanomedicine opportunities with perfluorocarbon nanoparticles.
    Winter PM, Cai K, Caruthers SD, Wickline SA, Lanza GM.
    Expert Rev Med Devices; 2007 Mar 08; 4(2):137-45. PubMed ID: 17359221
    [Abstract] [Full Text] [Related]

  • 17. Nanomedicine: developing smarter therapeutic and diagnostic modalities.
    Farokhzad OC, Langer R.
    Adv Drug Deliv Rev; 2006 Dec 01; 58(14):1456-9. PubMed ID: 17070960
    [Abstract] [Full Text] [Related]

  • 18. Application of nanotechnology in biomedicine.
    Navalakhe RM, Nandedkar TD.
    Indian J Exp Biol; 2007 Feb 01; 45(2):160-5. PubMed ID: 17375555
    [Abstract] [Full Text] [Related]

  • 19. Nanomedicine: application of nanobiotechnology in medical practice.
    Jain KK.
    Med Princ Pract; 2008 Feb 01; 17(2):89-101. PubMed ID: 18287791
    [Abstract] [Full Text] [Related]

  • 20. Beyond biotechnology: FDA regulation of nanomedicine.
    Miller J.
    Columbia Sci Technol Law Rev; 2003 Feb 01; 4():E5. PubMed ID: 15977335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.